x
Skip Navigation
Breaking News
More () »

FDA approves new drug that could slow progression of early symptomatic Alzheimer's disease

More Videos

Next up in 5

Example video title will go here for this video
In a large trial, it slowed the decline of cognitive function overall about 22% over 18 months.

Before You Leave, Check This Out